Actively Recruiting

Phase 1
Age: 21Years - 65Years
All Genders
Healthy Volunteers
NCT05962229

Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine

Led by University of California, San Francisco · Updated on 2026-05-14

18

Participants Needed

1

Research Sites

125 weeks

Total Duration

On this page

Sponsors

U

University of California, San Francisco

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

In a crossover study, experienced electronic cigarette users will vape 3 different forms of nicotine: natural (derived from tobacco), synthetic, or a 50:50 mixture of both natural and synthetic. The investigators will compare nicotine metabolism, cardiovascular effects, patterns of self-administration, and participants' feelings of craving/withdrawal and enjoyment.

CONDITIONS

Official Title

Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine

Who Can Participate

Age: 21Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy based on medical history and physical exam
  • Current regular user of electronic cigarettes at least 15 days in the past 30 days
  • Age between 21 and 65 years
Not Eligible

You will not qualify if you...

  • Use of medications that induce nicotine metabolizing enzyme CYP2A6 (e.g., rifampicin, carbamazepine, phenobarbital)
  • Use of sympatholytic medications for cardiovascular conditions (e.g., beta or alpha-blockers)
  • Use of nicotine-containing medications (e.g., patch, lozenge, gum)
  • Use of stimulant medications generally given for ADHD treatment (e.g., Adderall)
  • Pregnancy or breastfeeding
  • Women of childbearing potential not using acceptable contraception
  • Unable to read and write in English
  • Known allergy to propylene glycol or vegetable glycerin
  • Uncomfortable with blood draws

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Zuckerberg San Francisco General Hospital (ZSFG)

San Francisco, California, United States, 94110

Actively Recruiting

Loading map...

Research Team

L

Lisa Lawrence

CONTACT

A

Armando Barraza

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here